St Elevation Myocardial Infarction

A comprehensive STEMI protocol led to reductions in sex disparities in guideline-directed medical therapy, door-to-balloon time, in-hospital mortality and ischemic in-hospital events, according to new data.

For patients with unstable angina or non-STEMI referred for coronary angiography, the use of fentanyl as an analgesic for chest pain slowed the absorption of ticagrelor, resulting in greater platelet reactivity compared with lignocaine.

For patients with STEMI and multivessel CAD, complete revascularization reduced major CV events regardless of whether the primary mode of reperfusion was pharmacoinvasive or primary PCI, according to new data from the COMPLETE trial.

Ticagrelor (Brilinta, AstraZeneca) as orodispersible tablet vs. standard coated tablet for patients with ACS undergoing PCI.

Platelet inhibition with ticagrelor in an orodispersible tablet was similar to its standard coated form in patients with ACS undergoing PCI, according to results of the TASTER trial.

Fractional flow reserve-guided strategy vs. angiography-guided strategy for PCI in patients with STEMI and multivessel disease.

More extensive stenting improved coronary perfusion and reduced myocardial injury among high-risk patients with spontaneous coronary artery dissection, but was linked to elevated risk for procedural complications, researchers reported.

The American Heart Association and the Emirates Cardiac Society, a non-profit focused on cardiology, launched a new program that provides Chest Pain Center certifications to hospitals in the Middle East, according to a press release.

The American College of Cardiology’s Global Heart Attack Treatment Initiative had considerable positive influence on care delivery for MIs in low- and middle-income countries, according to a presentation at the ACC Scientific Session.

The use of CABG has declined dramatically in MI admissions, particularly in STEMI, according to a presentation at the American College of Cardiology Scientific Session.